Skip to main content
TipRanks
Go Ultimate75% OFF

Cochlear (OC5) Stock Forecast & Price Target

5 Followers
See the Price Targets and Ratings of:

OC5 Analyst Ratings

Hold
10Ratings
0Buy10Hold0Sell
Based on 10 analysts giving stock ratings to Cochlear in the past 3 months

OC5 Stock 12 Month Forecast

€84.96▼(-8.10% Downside)
Based on 10 Wall Street analysts offering 12 month price targets for Cochlear in the last 3 months. The average price target is EUR 84.96 with a high forecast of EUR 101.32 and a low forecast of EUR 71.84. The average price target represents a -8.10% change from the last price of EUR 92.45.
Highest Price Target€101.32Average Price Target€84.96Lowest Price Target€71.84

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:OC5
Price TargetArticle
Morgan Stanley€81.67hold-11.66%DownsideReiterated11/16/26
Citi€85.97hold-7.01%DownsideReiterated11/15/26
Macquarie Analyst forecast on DE:OC5Unknown AnalystNot RankedMacquarie€76.14hold-17.64%DownsideReiterated11/08/26
UBS€82.90hold-10.33%DownsideReiterated11/03/26
Ord Minnett Analyst forecast on DE:OC5Unknown AnalystNot RankedOrd Minnett€84.74hold-8.34%DownsideReiterated10/04/26
RBC Capital€71.84hold-22.29%DownsideReiterated09/15/26
Morgans€85.00hold-8.06%DownsideReiterated08/20/26
Jefferies€78.84→€88.88hold-3.86%DownsideReiterated08/20/26
Jarden€101.32hold9.59%UpsideReiterated08/19/26
J.P. Morgan€73.32→€91.12hold-1.43%DownsideReiterated08/19/26
Canaccord Genuity€181.14→€73.69buy-20.30%DownsideReiterated04/29/26
Goldman Sachs Analyst forecast on DE:OC5Unknown AnalystNot RankedGoldman Sachs€150.38→€132.51hold43.33%UpsideReiterated03/13/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
QUITAchieve Life Sciences
COGTCogent Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cochlear

3 Months
Shane Storey
Shane StoreyCanaccord Genuity
Success Rate5/9 ratings generated profit
56%
Average Return
-3.96%

Copying Shane Storey's trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of -3.96% per trade.

1 Year
Shane Storey
Shane StoreyCanaccord Genuity
Success Rate2/9 ratings generated profit
22%
Average Return
-15.30%

Copying Shane Storey's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -15.30% per trade.

2 Years
Shane Storey
Shane StoreyCanaccord Genuity
Success Rate2/9 ratings generated profit
22%
Average Return
-16.76%

Copying Shane Storey's trades and holding each position for 2 Years would result in 22.22% of your transactions generating a profit, with an average return of -16.76% per trade.

OC5 Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for OC5
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy00000
Hold1020222215
Sell11100
Strong Sell00000
total1121232215

In the current month, OC5 has received 0 Buy Ratings, 15 Hold Ratings, and 0 Sell Ratings. OC5 average Analyst price target in the past 3 months is 84.96.

OC5 Financial Forecast

€0€0.75€1.5€2.25€3Q4 2025Q4 2026Q2 2027
High€2.02
Consensus€1.64
Low€1.49

OC5 Earnings Forecast

Next quarter’s earnings estimate for OC5 is EUR 1.64 with a range of EUR 1.49 to EUR 2.02. The previous quarter’s EPS was EUR 1.23. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€728.6M€746.1M€763.7M€781.2M€798.8MQ4 2025Q4 2026Q2 2027
High€799M
Consensus€753M
Low€729M

OC5 Sales Forecast

Next quarter’s sales forecast for OC5 is EUR 752.86M with a range of EUR 728.56M to EUR 798.76M. The previous quarter’s sales results were EUR 732.79M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

OC5 Stock Forecast FAQ

What is DE:OC5’s average 12-month price target, according to analysts?
Based on analyst ratings, Cochlear ’s 12-month average price target is €84.96.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Cochlear a Buy, Sell or Hold?
Cochlear has a consensus rating of Hold, which is based on 0 buy ratings, 10 hold ratings and 0 sell ratings.
What is Cochlear ’s share price target?
The average share price target for Cochlear is €84.96. This is based on 10 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €101.32, and the lowest forecast is €71.84. The average share price target represents a 8.10% decrease from the current price of €92.45.
What do analysts say about Cochlear ?
Cochlear ’s analyst rating consensus is a Hold. This is based on the ratings of 10 Wall Street analysts.
How can I buy shares of Cochlear ?
To buy shares of DE:OC5, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.